Full Text
<article class="scholarly-article">
<h2>Introduction</h2>
<p>The landscape of gene regulation has been dramatically expanded by the discovery and characterization of non-coding RNAs (ncRNAs). Among these, circular RNAs (circRNAs) have garnered significant attention due to their unique structure and diverse functional capabilities [1, 9, 16]. Unlike linear RNAs, circRNAs are formed through a process of back-splicing, resulting in a covalently closed loop structure that confers resistance to degradation by exonucleases [1, 16]. This inherent stability allows circRNAs to persist within cells and exert sustained regulatory effects. Initially considered transcriptional byproducts, circRNAs are now recognized as crucial players in a multitude of cellular processes, including gene expression modulation, protein scaffolding, and the regulation of epigenetic modifications [1, 18]. Their dysregulation has been increasingly linked to various human diseases, particularly cancers, positioning them as potential diagnostic and prognostic biomarkers [5, 7, 8, 10, 19]. This review aims to consolidate the current understanding of circRNA biology, focusing on their biogenesis, mechanisms of action, and their multifaceted roles in health and disease, with an emphasis on recent advancements in the field as of early 2024.</p>
<h2>Literature Review</h2>
<p>The study of ncRNAs has revolutionized our understanding of molecular biology. Small non-coding RNAs, such as microRNAs (miRNAs), have been extensively studied for their roles in post-transcriptional gene silencing [3, 6]. However, the discovery of longer non-coding RNAs (lncRNAs) and, more recently, circRNAs, has revealed additional layers of regulatory complexity [13, 29]. CircRNAs are generated from precursor messenger RNAs (pre-mRNAs) through a process known as back-splicing, where a 3' splice site is covalently linked to an upstream 5' splice site [1]. This process can occur either linearly or exponentially, and is influenced by factors such as spliceosome machinery, RNA-binding proteins (RBPs), and the presence of complementary sequences like Alu repeats [1, 16].</p><p>The functional repertoire of circRNAs is remarkably diverse. One of the most well-established mechanisms is their role as miRNA sponges [16]. By binding to specific miRNAs, circRNAs can sequester them, thereby preventing the miRNAs from binding to their target messenger RNAs (mRNAs) and inhibiting translation. This effectively leads to the upregulation of the target genes [3, 16]. For instance, certain circRNAs have been shown to regulate epithelial-to-mesenchymal transition by sponging miRNAs involved in this process [30]. Beyond miRNA sponging, circRNAs can interact with RBPs, influencing their localization, activity, or availability. Some circRNAs can act as scaffolds, bringing together multiple proteins to form functional complexes [1, 18]. Others may even be translated into peptides, although this is a less common phenomenon compared to their non-coding functions [1].</p><p>The involvement of circRNAs in developmental processes and cellular differentiation is also becoming increasingly apparent [2, 21]. For example, specific circRNAs have been identified in spermatogonial stem cells, suggesting a role in germline stem cell regulation [2]. Similarly, dynamic regulation of circRNAs has been observed in adipose tissue, with implications for adipogenesis and obesity [21]. Furthermore, circRNAs have been implicated in immune responses, mediating cellular communication and influencing the effectiveness of cancer therapies [18, 20]. The regulatory potential of enhancer RNAs (eRNAs), which are transcribed from enhancer regions, also contributes to the intricate network of gene regulation, often through epigenetic mechanisms [4].</p><p>The aberrant expression of circRNAs is strongly associated with various pathological conditions, most notably cancer [5, 7, 8, 10, 23]. Numerous studies have identified specific circRNAs that are differentially expressed in tumors compared to normal tissues, serving as potential biomarkers for early diagnosis, prognosis, and even predicting response to therapy [7, 8]. For example, circRNAs have been implicated in the pathogenesis of malignant melanoma [5], oral squamous cell carcinoma [10], and lung cancer [7, 23]. Their roles extend to other diseases as well, including coronary artery disease [19] and pancreatic beta cell dysfunction [15]. The development of advanced sequencing technologies and bioinformatics tools has been instrumental in the discovery and functional annotation of circRNAs, facilitating a deeper understanding of their biological significance [26, 27, 28].</p>
<h2>Methodology</h2>
<p>This review synthesizes information from peer-reviewed literature published up to January 2024. A comprehensive search strategy was employed using major scientific databases, including PubMed, Scopus, Web of Science, and Google Scholar. Keywords used in the search included "circular RNA", "circRNA", "gene regulation", "miRNA sponge", "RNA-binding protein", "epigenetics", "cancer", "biomarker", and "transcriptomics". Studies focusing on circRNA biogenesis, function, and their roles in disease were prioritized. Both original research articles and review papers were included to provide a broad overview and detailed insights into specific areas. Special attention was given to studies employing high-throughput sequencing technologies (e.g., RNA-seq) for circRNA identification and quantification, as well as experimental validation methods such as CRISPR-Cas9 screening [25] and knockdown/overexpression studies.</p><p>Data extraction focused on identifying reported mechanisms of circRNA action, their involvement in specific cellular pathways, and their association with disease states. For illustrative purposes, hypothetical datasets were generated to represent typical findings in circRNA research. These simulated data, presented in tables and figures, reflect common observations regarding circRNA expression levels, their correlation with clinical parameters, and their functional impacts. The analysis of these simulated datasets is intended to demonstrate the types of evidence used to support the roles of circRNAs in gene regulation and disease. Statistical methods commonly applied in circRNA research, such as differential expression analysis and correlation analysis, would typically be employed to analyze such data.</p>
<h2>Results</h2>
<p>The exponential growth in circRNA research has revealed a diverse array of circRNAs with significant regulatory functions. Numerous studies have cataloged circRNAs across various species and cell types, highlighting their prevalence in the transcriptome [1, 16]. Back-splicing, the canonical mechanism for circRNA formation, is influenced by cis-acting elements and trans-acting factors, leading to the production of a stable circular molecule [1].</p><p><h4>Mechanisms of CircRNA Action</h4></p><p>The primary characterized mechanism by which circRNAs regulate gene expression is through acting as miRNA sponges [3, 16]. By titrating away specific miRNAs, circRNAs can relieve the repression of miRNA target genes. For example, a hypothetical study might identify a circRNA, let's call it circXYZ, that contains multiple binding sites for miR-123. If circXYZ expression is high, it would sequester miR-123, leading to increased expression of miR-123 target genes, such as GeneA. Conversely, knockdown of circXYZ would lead to increased miR-123 activity and decreased GeneA expression.</p><p><figure class="article-figure"><figcaption>Figure 1. schematic illustrating circRNA acting as a miRNA sponge</figcaption></figure></p><p>Another significant mechanism involves the interaction of circRNAs with RBPs. These interactions can sequester RBPs, alter their cellular localization, or facilitate the formation of RBP-RNA complexes. For instance, certain circRNAs have been shown to bind to proteins involved in splicing or translation [1, 18].</p><p><h4>CircRNAs in Disease Pathogenesis</h4></p><p>The dysregulation of circRNAs is a common feature in many human diseases, particularly cancer. Their stability and tissue-specific expression patterns make them attractive candidates for diagnostic and prognostic biomarkers [7, 8].</p><p><h4>Hypothetical CircRNA Expression in Lung Cancer</h4></p><p>To illustrate the potential of circRNAs as biomarkers, consider a hypothetical analysis of circRNA expression in non-small cell lung cancer (NSCLC) patients compared to healthy controls. RNA sequencing data might reveal a set of differentially expressed circRNAs. The following table presents a subset of these hypothetical findings, including fold change and p-values.</p><p></p><figure class="table-figure"><table><thead><tr><th>CircRNA ID</th><th>Tumor (n=50) Mean Expression</th><th>Control (n=50) Mean Expression</th><th>Fold Change (Tumor/Control)</th><th>p-value</th></tr></thead><tbody><tr><td>hsa_circ_0001234</td><td>150.2</td><td>45.5</td><td>3.30</td><td>0.0001</td></tr><tr><td>hsa_circ_0005678</td><td>95.8</td><td>110.1</td><td>0.87</td><td>0.15</td></tr><tr><td>hsa_circ_0123456</td><td>205.7</td><td>30.2</td><td>6.81</td><td><0.0001</td></tr><tr><td>hsa_circ_0987654</td><td>12.3</td><td>8.9</td><td>1.38</td><td>0.025</td></tr></tbody></table><figcaption>Table 1. Differential expression of selected hypothetical circRNAs in non-small cell lung cancer (NSCLC) compared to controls. Higher expression values indicate greater abundance of the circRNA.</figcaption></figure><p></p><p>As shown in Table 1, hsa_circ_0123456 and hsa_circ_0001234 exhibit significantly higher expression in NSCLC tumors, while hsa_circ_0005678 is downregulated. hsa_circ_0987654 shows a modest but statistically significant upregulation. These findings would warrant further investigation into the functional roles of these circRNAs in NSCLC progression.</p><p>Furthermore, studies have explored the role of circRNAs in regulating drug resistance. For example, certain circRNAs might confer resistance to chemotherapy by sponging miRNAs that target key drug-metabolizing enzymes or drug transporters [7].</p><p><h4>Correlation of CircRNA Expression with Clinical Parameters</h4></p><p>In a hypothetical cohort of patients with oral squamous cell carcinoma (OSCC), researchers might investigate the correlation between the expression of a specific circRNA, say circOSCC-1, and clinical parameters such as tumor stage and lymph node metastasis. The following table presents simulated correlation coefficients.</p><p></p><figure class="table-figure"><table><thead><tr><th>Clinical Parameter</th><th>Correlation Coefficient (r)</th><th>p-value</th></tr></thead><tbody><tr><td>Tumor Stage (I-IV)</td><td>0.65</td><td>0.001</td></tr><tr><td>Lymph Node Metastasis (N0-N3)</td><td>0.52</td><td>0.008</td></tr><tr><td>Tumor Grade (G1-G3)</td><td>0.31</td><td>0.09</td></tr><tr><td>Patient Age (years)</td><td>0.15</td><td>0.35</td></tr></tbody></table><figcaption>Table 2. Correlation between hypothetical circOSCC-1 expression and clinical parameters in oral squamous cell carcinoma (OSCC).</figcaption></figure><p></p><p>Table 2 indicates a strong positive correlation between circOSCC-1 expression and both tumor stage and lymph node metastasis, suggesting its potential role in promoting OSCC progression and invasiveness [10].</p><p>The diverse roles of circRNAs extend to developmental biology and cellular differentiation [2, 21]. For instance, specific circRNAs have been identified in stem cells, where they may play critical roles in maintaining stemness or directing differentiation pathways [2, 21].</p><p><figure class="article-figure"><figcaption>Figure 2. Venn diagram showing overlap of differentially expressed circRNAs in different cancer types</figcaption></figure></p>
<h2>Discussion</h2>
<p>The burgeoning field of circRNA research continues to unveil the complexity and significance of these molecules in cellular regulation. As of early 2024, it is clear that circRNAs are not mere transcriptional noise but active participants in gene expression networks [1, 16]. Their unique circular structure confers stability, allowing them to exert sustained regulatory effects that linear RNAs may not achieve [1].</p><p>The primary function of circRNAs as miRNA sponges has been extensively validated. This mechanism provides a sophisticated layer of post-transcriptional control, enabling cells to fine-tune gene expression in response to various stimuli [3, 16]. The ability of a single circRNA to bind multiple miRNAs, and for a single miRNA to interact with numerous circRNAs, suggests a complex regulatory web where feedback loops and crosstalk are prevalent [16]. This intricate network offers potential targets for therapeutic intervention, where modulating specific circRNA-miRNA interactions could restore normal cellular function [7].</p><p>Beyond miRNA sponging, the emerging roles of circRNAs in interacting with RBPs and forming protein scaffolds are particularly exciting [1, 18]. These interactions can influence a wide range of cellular processes, from RNA processing and translation to signal transduction and epigenetic modification [1, 18]. For instance, circRNAs associated with chromatin remodeling complexes could play a direct role in regulating gene accessibility and transcription [4, 13]. The discovery that some circRNAs can be translated into peptides, albeit less common, adds another dimension to their functional landscape [1].</p><p>The strong association between circRNA dysregulation and disease, especially cancer, underscores their diagnostic and prognostic potential [5, 7, 8, 10, 19, 23]. The hypothetical data presented in Table 1 and Table 2 exemplify how differential expression and correlation analyses can identify circRNAs implicated in disease progression. These findings align with numerous published studies that have identified specific circRNAs as potential biomarkers for various cancers, including lung cancer and oral squamous cell carcinoma [7, 10, 23]. The stability of circRNAs in biological fluids like blood also makes them promising candidates for non-invasive liquid biopsies [8].</p><p>However, challenges remain. The accurate and comprehensive identification of all circRNAs, especially low-abundance ones, requires sophisticated sequencing and bioinformatics approaches [26, 27, 28]. Functional validation of identified circRNAs can be labor-intensive, often requiring genetic manipulation (e.g., CRISPR-Cas9) or the development of specific molecular tools [25]. Furthermore, understanding the precise in vivo mechanisms and the full spectrum of circRNA targets requires continued investigation. The intricate interplay between circRNAs, miRNAs, RBPs, and other regulatory molecules necessitates a systems biology approach to fully unravel their regulatory networks [11].</p><p>The role of circRNAs in fundamental biological processes such as development and stem cell biology [2, 21] is an area ripe for further exploration. Understanding how circRNAs contribute to cell fate decisions and tissue homeostasis could provide insights into developmental disorders and regenerative medicine.</p>
<h2>Conclusion</h2>
<p>Circular RNAs have firmly established themselves as vital components of the regulatory transcriptome. Their unique structure confers stability, enabling them to participate in sophisticated gene regulatory mechanisms, most notably as miRNA sponges and RBP interactors [1, 3, 16, 18]. The growing body of evidence linking circRNA dysregulation to a wide range of human diseases, particularly cancers, highlights their significant potential as diagnostic, prognostic, and therapeutic targets [5, 7, 8, 10, 19]. While challenges in circRNA identification and functional validation persist, ongoing advancements in sequencing technology and molecular biology tools are rapidly expanding our understanding of their multifaceted roles [26, 27, 28]. Future research will undoubtedly continue to uncover novel circRNA functions and their implications in both health and disease, further solidifying their importance in molecular biology and translational medicine.</p>
<h2>References</h2>
<ol class="references">
<li>Andreeva, K., Cooper, N. G. F.. Circular RNAs: New Players in Gene Regulation. Advances in Bioscience and Biotechnology. 2015;06(06), 433-441. https://doi.org/10.4236/abb.2015.66043</li>
<li>Zhou, F., Chen, W., Jiang, Y., He, Z.. Regulation of long non-coding RNAs and circular RNAs in spermatogonial stem cells. Reproduction. 2019;158(1), R15-R25. https://doi.org/10.1530/rep-18-0517</li>
<li>He, L., Hannon, G. J.. MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics. 2004;5(7), 522-531. https://doi.org/10.1038/nrg1379</li>
<li>Rahnamoun, H., Orozco, P., Lauberth, S. M.. The role of enhancer RNAs in epigenetic regulation of gene expression. Transcription. 2019;11(1), 19-25. https://doi.org/10.1080/21541264.2019.1698934</li>
<li>Cong, L., Yang, H., Sun, H., Hao, M., Liu, C., Zheng, Y.. Role of Circular RNAs in the Pathogenesis of Malignant Melanoma. Critical Reviews in Eukaryotic Gene Expression. 2022;32(3), 21-30. https://doi.org/10.1615/critreveukaryotgeneexpr.2021040319</li>
<li>He, L., Hannon, G. J.. Correction: MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics. 2004;5(8), 631-631. https://doi.org/10.1038/nrg1415</li>
<li>Sang, C., Rao, D., Wu, C., Xia, Y., Si, M., Tang, Z.. Role of circular RNAs in the diagnosis, regulation of drug resistance and prognosis of lung cancer (Review). Oncology Letters. 2022;24(3). https://doi.org/10.3892/ol.2022.13422</li>
<li>Wei, G., Zhu, J., Hu, H., Liu, J.. Circular RNAs: Promising biomarkers for cancer diagnosis and prognosis. Gene. 2021;771, 145365. https://doi.org/10.1016/j.gene.2020.145365</li>
<li>Vidal, A. F., Sandoval, G. T., Magalhães, L., Santos, S. E., Ribeiro-dos-Santos, Â.. Circular RNAs as a New Field in Gene Regulation and their Implications in Translational Research. Epigenomics. 2016;8(4), 551-562. https://doi.org/10.2217/epi.16.3</li>
<li>Attar, R., Noel, K., Romero, M. A., Sabitaliyevich, U. Y., Yulaevna, I. M., Qureshi, M. Z.. Regulatory role of circular RNAs in oral squamous cell carcinoma. Cellular and Molecular Biology. 2023;69(8), 250-257. https://doi.org/10.14715/cmb/2023.69.8.39</li>
<li>Romby, P., Vandenesch, F., Wagner, E. G. H.. The role of RNAs in the regulation of virulence-gene expression. Current Opinion in Microbiology. 2006;9(2), 229-236. https://doi.org/10.1016/j.mib.2006.02.005</li>
<li>Chen, Y., Yuan, B., Wu, Z., Dong, Y., Zhang, L., Zeng, Z.. Microarray profiling of circular RNAs and the potential regulatory role of hsa_circ_0071410 in the activated human hepatic stellate cell induced by irradiation. Gene. 2017;629, 35-42. https://doi.org/10.1016/j.gene.2017.07.078</li>
<li>Umlauf, D., Fraser, P., Nagano, T.. The role of long non-coding RNAs in chromatin structure and gene regulation: variations on a theme. bchm. 2008;389(4), 323-331. https://doi.org/10.1515/bc.2008.047</li>
<li>Chen, G.. Abstract 2580: Regulation and Functions of Circular RNAs. Journal of Biological Chemistry. 2023;299(3), 104256. https://doi.org/10.1016/j.jbc.2023.104256</li>
<li>Das, D., Das, A., Panda, A. C.. Emerging role of long noncoding RNAs and circular RNAs in pancreatic β cells. Non-coding RNA Investigation. 2018;2, 69-69. https://doi.org/10.21037/ncri.2018.11.02</li>
<li>Huang, S., Yang, B., Chen, B., Bliim, N., Ueberham, U., Arendt, T.. The emerging role of circular RNAs in transcriptome regulation. Genomics. 2017;109(5-6), 401-407. https://doi.org/10.1016/j.ygeno.2017.06.005</li>
<li>Kay, M. A.. The Role of tRNA Derived Small RNAs in Gene Regulation in Normal Tissues and Cancer. The FASEB Journal. 2020;34(S1), 1-1. https://doi.org/10.1096/fasebj.2020.34.s1.00158</li>
<li>Yang, L., Fu, J., Zhou, Y.. Circular RNAs and Their Emerging Roles in Immune Regulation. Frontiers in Immunology. 2018;9. https://doi.org/10.3389/fimmu.2018.02977</li>
<li>Ghafouri-Fard, S., Gholipour, M., Taheri, M.. The Emerging Role of Long Non-coding RNAs and Circular RNAs in Coronary Artery Disease. Frontiers in Cardiovascular Medicine. 2021;8. https://doi.org/10.3389/fcvm.2021.632393</li>
<li>Carlos-Reyes, Á., Romero-Garcia, S., Contreras-Sanzón, E., Ruiz, V., Prado-Garcia, H.. Role of Circular RNAs in the Regulation of Immune Cells in Response to Cancer Therapies. Frontiers in Genetics. 2022;13. https://doi.org/10.3389/fgene.2022.823238</li>
<li>Arcinas, C., Tan, W., Fang, W., Desai, T. P., Teh, D. C. S., Degirmenci, U.. Adipose circular RNAs exhibit dynamic regulation in obesity and functional role in adipogenesis. Nature Metabolism. 2019;1(7), 688-703. https://doi.org/10.1038/s42255-019-0078-z</li>
<li>Wang, X., Chang, X., Ya, J., Zhao, J., Fang, Q., Sun, M.. Identification and functional prediction of soybean CircRNAs involved in low-temperature responses. Journal of Plant Physiology. 2020;250, 153188-153188. https://doi.org/10.1016/j.jplph.2020.153188</li>
<li>Sun, Q., Li, X., Xu, M., Zhang, L., Zuo, H., Xin, Y.. Differential Expression and Bioinformatics Analysis of circRNA in Non-small Cell Lung Cancer. Frontiers in Genetics. 2020;11, 586814-586814. https://doi.org/10.3389/fgene.2020.586814</li>
<li>Collins, F. S., Green, E. D., Guttmacher, A. E., Guyer, M. S.. A vision for the future of genomics research. Nature. 2003;422(6934), 835-847. https://doi.org/10.1038/nature01626</li>
<li>Sanson, K. R., Hanna, R. E., Hegde, M., Donovan, K., Strand, C., Sullender, M. E.. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nature Communications. 2018;9(1), 5416-5416. https://doi.org/10.1038/s41467-018-07901-8</li>
<li>Kieft, K., Zhou, Z., Anantharaman, K.. VIBRANT: automated recovery, annotation and curation of microbial viruses, and evaluation of viral community function from genomic sequences. Microbiome. 2020;8(1), 90-90. https://doi.org/10.1186/s40168-020-00867-0</li>
<li>Zhao, Q., Xu, Q., Serafino, M., Zhang, Q., Wang, C., Yu, Y.. Comprehensive analysis of circular RNAs in porcine small intestine epithelial cells associated with susceptibility to Escherichia coli F4ac diarrhea. BMC Genomics. 2023;24(1), 211-211. https://doi.org/10.1186/s12864-022-08994-8</li>
<li>Wang, B., Tseng, E., Regulski, M., Clark, T. A., Hon, T., Jiao, Y.. Unveiling the complexity of the maize transcriptome by single-molecule long-read sequencing. Nature Communications. 2016;7(1), 11708-11708. https://doi.org/10.1038/ncomms11708</li>
<li>Kapusta, A., Kronenberg, Z., Lynch, V. J., Zhuo, X., Ramsay, L., Bourque, G.. Transposable Elements Are Major Contributors to the Origin, Diversification, and Regulation of Vertebrate Long Noncoding RNAs. PLoS Genetics. 2013;9(4), e1003470-e1003470. https://doi.org/10.1371/journal.pgen.1003470</li>
<li>Liang, W., Fu, W., Wong, C., Wang, Y., Wang, W., Guo-xin, H.. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015;6(26), 22513-22525. https://doi.org/10.18632/oncotarget.4154</li>
</ol>
</article>